GSK warns vaccines no longer profitable, Belgian jobs at risk

GSK has warned employees that its vaccine business is no longer sufficiently profitable, signaling a potential restructuring at its Belgian sites in Wavre and Rixensart. The works council meeting is expected to be short, which workers interpret as a negative sign. This marks a strategic shift for GSK, which has long been a major vaccine producer, and could impact global vaccine supply and the Belgian economy.